Works matching IS 16197070 AND DT 2025 AND VI 52 AND IP 4

Results: 36

Cross-modality PET image synthesis for Parkinson's Disease diagnosis: a leap from [18F]FDG to [11C]CFT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1566, doi. 10.1007/s00259-025-07096-3

By:

Shen, Zhenrong;
Wang, Jing;
Huang, Haolin;
Lu, Jiaying;
Ge, Jingjie;
Xiong, Honglin;
Wu, Ping;
Ju, Zizhao;
Lin, Huamei;
Zhu, Yuhua;
Yang, Yunhao;
Liu, Fengtao;
Guan, Yihui;
Sun, Kaicong;
Wang, Jian;
Wang, Qian;
Zuo, Chuantao

Publication type:

Article

Association of objective subtle cognitive difficulties with amyloid-β and tau deposition compared to subjective cognitive decline.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1481, doi. 10.1007/s00259-025-07080-x

By:

Mao, Xiaoxie;
Li, Anqi;
Wang, Ying;
Wang, Yan;
Ren, Shuhua;
He, Kun;
Guan, Yihui;
Huang, Qi;
Guo, Qihao;
Li, Zijing;
Guo, Tengfei;
Xie, Fang

Publication type:

Article

[18F]FDG PET/CT for predicting neoadjuvant PD-L1 blockade monotherapy treatment response in patients with locally advanced esophageal squamous cell carcinoma: a preliminary study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1422, doi. 10.1007/s00259-024-07051-8

By:

Yang, Runjun;
Tang, Han;
Xie, Yunze;
Cai, Danjie;
He, Yibo;
Zheng, Zhe;
Lin, Yu;
Gao, Huaping;
Tang, Wenxin;
Yan, Yihan;
Tan, Lijie;
Shi, Hongcheng

Publication type:

Article

Dual-energy x-ray absorptiometry (DXA) in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM).

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1237, doi. 10.1007/s00259-024-07050-9

By:

Punda, Marija;
Zhang-Yin, Jules;
Erba, Paula Anna;
Graham, Richard;
Khan, Aliya A.;
Lems, Willem F.;
Slart, Riemer H. J. A.

Publication type:

Article

Molecular imaging: The bridge from human phenome to personalized precision medicine.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1233, doi. 10.1007/s00259-024-07048-3

By:

Tian, Mei;
Gao, Yidan;
Xue, Chenxi;
Jin, Chentao;
Zhang, Hong

Publication type:

Article

PSMA-targeted radioligand therapy in metastatic prostate cancer: Comprehensive analysis of recent evidence.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1242, doi. 10.1007/s00259-024-07041-w

By:

Petranović Ovčariček, Petra;
Garo, Maria Luisa;
Giovanella, Luca

Publication type:

Article

Cardiovascular disease and radiopharmaceutical therapies– an underestimated risk?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1246, doi. 10.1007/s00259-024-07039-4

By:

Lassmann, Michael;
Eberlein, Uta;
Verburg, Frederik A.

Publication type:

Article

Assessment of fully quantitative and simplified methods for analysis of [68Ga]Ga-FAPI-46 uptake in patients with pancreatobiliary cancer using LAFOV PET/CT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1472, doi. 10.1007/s00259-024-07037-6

By:

Palard-Novello, Xavier;
Henrar, Rutger B.;
Oprea-Lager, Daniela E.;
Cysouw, Matthijs C. F.;
Schober, Patrick;
de Geus-Oei, Lioe-Fee;
Vahrmeijer, Alexander L.;
Hendrikse, Harry;
Kazemier, Geert;
den Hollander, Marijke;
Schuit, Robert C.;
Windhorst, Albert D.;
Boellaard, Ronald;
Swijnenburg, Rutger-Jan;
Yaqub, Maqsood

Publication type:

Article

Exploration of (R)-[11C]YH168 as a PET tracer for imaging monoacylglycerol lipase in the brain: from mice to non-human primates.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1556, doi. 10.1007/s00259-024-07013-0

By:

He, Yingfang;
Zheng, MingQiang;
Gu, Jiwei;
Reichert, Lisa;
Trimborn, Johannes;
Zhang, Hui;
Keller, Claudia;
Crosby, Mallory;
Collin, Ludovic;
Heer, Dominik;
Pavlovic, Anto;
Topp, Andreas;
Wittwer, Matthias Beat;
Grether, Uwe;
Gobbi, Luca;
Schibli, Roger;
Huang, Yiyun;
Mu, Linjing

Publication type:

Article

Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1257, doi. 10.1007/s00259-024-07000-5

By:

Zhang, Jingfeng;
Niu, Shaoxi;
Liu, Yachao;
Zhang, Xiaojun;
Luan, Xiaohui;
Liu, Huanhuan;
Pan, Yue;
Xu, Xiaodan;
Wu, Shina;
Wang, Yuan;
Chen, Zhiqiang;
Wang, Baojun;
Zhang, Xu;
Wang, Ruimin;
Zhang, Jinming;
Xu, Baixuan

Publication type:

Article

Human dose-escalation study of PET imaging CD8+ T-cell infiltration in solid malignancies with [68Ga]Ga -NODAGA-SNA006.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1332, doi. 10.1007/s00259-024-06999-x

By:

Wang, Yan;
Zheng, Meng;
Zhao, Jun;
Wang, Chao;
Zhao, Shandong;
Bian, Yicong;
Dai, Na;
Zheng, Yushuang;
Sang, Shibiao;
Guo, Linchuan;
Huang, Chenrong;
Zhang, Hua;
Jiang, Jiwei;
Xu, Chun;
Zhao, Qi;
Han, Jiajun;
Xu, Tao;
Qin, Songbing;
Miao, Liyan

Publication type:

Article

Preclinical investigation of [149Tb]Tb-DOTATATE and [149Tb]Tb-DOTA-LM3 for tumor-targeted alpha therapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1383, doi. 10.1007/s00259-024-07035-8

By:

Mapanao, Ana Katrina;
Busslinger, Sarah D.;
Mehta, Avni;
Kegler, Kristel;
Favaretto, Chiara;
Grundler, Pascal V.;
Talip, Zeynep;
Köster, Ulli;
Johnston, Karl;
Schibli, Roger;
van der Meulen, Nicholas P.;
Müller, Cristina

Publication type:

Article

Subcortical tau deposition and plasma glial fibrillary acidic protein as predictors of cognitive decline in mild cognitive impairment and Alzheimer's disease.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1496, doi. 10.1007/s00259-024-07016-x

By:

Chang, Yan;
Liu, Jiajin;
Xu, Xiaodan;
Sun, Shuwei;
Zhang, Jinming;
Zhang, Xiaojun;
Lu, Guangshuang;
Xiao, Shaobo;
Cao, Yuanyan;
Wu, Runze;
Wu, Jun;
Liu, Ruozhuo;
Wang, Ruimin

Publication type:

Article

Systematic review: Mechanisms of photoactive nanocarriers for imaging and therapy including controlled drug delivery.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1576, doi. 10.1007/s00259-024-07014-z

By:

Zhang, Yapei;
Qiu, Yunxiu;
Karimi, Ali Bavandpour;
Smith, Bryan Ronain

Publication type:

Article

Evaluation of long axial field-of-view (LAFOV) PET/CT for post-treatment dosimetry in Yttrium-90 radioembolization of liver tumors: a comparative study with conventional SPECT imaging.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1460, doi. 10.1007/s00259-024-07034-9

By:

Zeimpekis, Konstantinos G.;
Sari, Hasan;
Gözlügöl, Nasir;
Achangwa, Ngwe Rawlings;
Shi, Kuangyu;
Schindewolf, Marc;
Afshar-Oromieh, Ali;
Rominger, Axel;
Seifert, Robert

Publication type:

Article

Distinguishing benign from malignant lesions with high [68 Ga]Ga-FAPI-04 uptake in oncology patients: Insights from dynamic total-body [68 Ga]Ga-FAPI-04 PET/CT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1345, doi. 10.1007/s00259-024-07029-6

By:

Chen, Ruohua;
Yang, Xinlan;
Li, Lianghua;
Zhao, Haitao;
Huang, Gang;
Liu, Jianjun

Publication type:

Article

Preclinical comparison of (radio)lanthanides using mass spectrometry and nuclear imaging techniques: biodistribution of lanthanide-based tumor-targeting agents and lanthanides in ionic form.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1370, doi. 10.1007/s00259-024-07018-9

By:

Wallimann, Rahel H.;
Mehta, Avni;
Mapanao, Ana Katrina;
Köster, Ulli;
Kneuer, Rainer;
Schindler, Patrick;
van der Meulen, Nicholas P.;
Schibli, Roger;
Müller, Cristina

Publication type:

Article

A deep learning method for total-body dynamic PET imaging with dual-time-window protocols.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1448, doi. 10.1007/s00259-024-07012-1

By:

Ding, Wenxiang;
Wang, Hanzhong;
Qiao, Xiaoya;
Li, Biao;
Huang, Qiu

Publication type:

Article

Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1354, doi. 10.1007/s00259-024-07007-y

By:

Yang, Liping;
Guo, Wei;
Ding, Hongchao;
Gao, Xing;
Xu, Yuchao;
Wang, Menglu;
Yang, Xinyue;
Zhao, Yue;
Wang, Wenzhi;
Liu, Wei;
Jia, Fan;
Hou, Dayong;
Nanding, Abiyasi;
Cheng, Liang;
Meng, Hongxue;
Wang, Kezheng

Publication type:

Article

Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1271, doi. 10.1007/s00259-024-07006-z

By:

Bastian, Moritz B.;
Sieben, Maike;
Blickle, Arne;
Burgard, Caroline;
Speicher, Tilman;
Bartholomä, Mark;
Schaefer-Schuler, Andrea;
Maus, Stephan;
Ezziddin, Samer;
Rosar, Florian

Publication type:

Article

Phase I study of [68Ga]Ga-HX01 for targeting integrin αvβ3 and CD13 in healthy and malignancy subjects.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1293, doi. 10.1007/s00259-024-07002-3

By:

Zhang, Xiao;
Fang, Hanyi;
Yang, Biao;
Qin, Chunxia;
Hu, Fan;
Ruan, Weiwei;
Chen, Jing;
Zeng, Dexing;
Gai, Yongkang;
Lan, Xiaoli

Publication type:

Article

Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1305, doi. 10.1007/s00259-024-07011-2

By:

Njotu, Fabrice N.;
Pougoue Ketchemen, Jessica;
Babeker, Hanan;
Henning, Nikita;
Tikum, Anjong F.;
Nwangele, Emmanuel;
Monzer, Alissar;
Hassani, Nava;
Gray, Brian D.;
Pak, Koon Y.;
Torlakovic, Emina E.;
Uppalapati, Maruti;
Fonge, Humphrey

Publication type:

Article

Self-supervised neural network for Patlak-based parametric imaging in dynamic [18F]FDG total-body PET.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1436, doi. 10.1007/s00259-024-07008-x

By:

Gu, Wenjian;
Zhu, Zhanshi;
Liu, Ze;
Wang, Yihan;
Li, Yanxiao;
Xu, Tianyi;
Liu, Weiping;
Luo, Gongning;
Wang, Kuanquan;
Zhou, Yun

Publication type:

Article

The cerebellar glucose metabolism in moyamoya vasculopathy and its correlation with neurocognitive performance after cerebral revascularization surgery: a [18F]FDG PET study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1520, doi. 10.1007/s00259-024-06995-1

By:

Weng, Ruiyuan;
Ren, Shuhua;
Su, Jiabin;
Jiang, Hanqiang;
Yang, Heng;
Gao, Xinjie;
Jiang, Zhiwen;
Fei, Yuchao;
Guan, Yihui;
Xie, Fang;
Ni, Wei;
Huang, Qi;
Gu, Yuxiang

Publication type:

Article

Presynaptic terminal integrity is associated with glucose metabolism in Parkinson's disease.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1510, doi. 10.1007/s00259-024-06993-3

By:

Wang, Weiyi;
Wang, Yanru;
Xu, Limin;
Liu, Xueling;
Hu, Yuqing;
Li, Junpeng;
Huang, Qi;
Ren, Shuhua;
Huang, Yiyun;
Guan, Yihui;
Li, Yuxin;
Hua, Fengchun;
Ye, Qing;
Xie, Fang

Publication type:

Article

Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1549, doi. 10.1007/s00259-024-06989-z

By:

Apostolova, Ivayla;
Hellwig, Sabine;
Karimzadeh, Amir;
Klutmann, Susanne;
Meyer, Philipp T.;
Buchert, Ralph

Publication type:

Article

Incorporating label uncertainty during the training of convolutional neural networks improves performance for the discrimination between certain and inconclusive cases in dopamine transporter SPECT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1535, doi. 10.1007/s00259-024-06988-0

By:

Kucerenko, Aleksej;
Buddenkotte, Thomas;
Apostolova, Ivayla;
Klutmann, Susanne;
Ledig, Christian;
Buchert, Ralph

Publication type:

Article

Radioiodinated Nanobody immunoPET probe for in vivo detection of CD147 in pan-cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1406, doi. 10.1007/s00259-024-06985-3

By:

Ma, Xiaokun;
Liu, Teli;
Guo, Rui;
Zhou, Wenyuan;
Yao, Yuan;
Wen, Dan;
Tao, Jinping;
Zhu, Jinyu;
Wang, Feng;
Zhu, Hua;
Yang, Zhi

Publication type:

Article

Correction To: Coronary artery calcium measurement on attenuation correction computed tomography using artificial intelligence: correlation with coronary flow capacity and prognosis.

Published in:

2025

By:

Cho, Sang-Geon;
Lee, Jong Eun;
Cho, Kyung Hoon;
Park, Ki-Seong;
Kim, Jahae;
Moon, Jang Bae;
Kim, Kang Bin;
Kim, Ju Han;
Song, Ho-Chun

Publication type:

Correction Notice

Comparison of clinical performance between late and standard total-body [68 Ga]Ga-PSMA-11 in biochemical recurrent prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1249, doi. 10.1007/s00259-024-06980-8

By:

Chen, Qiaochu;
Dong, Liang;
Xu, Lian;
Zhao, Haitao;
Li, Lianghua;
Huang, Gang;
Liu, Jianjun;
Chen, Ruohua

Publication type:

Article

Radiopharmaceutical formulation and preliminary clinical dosimetry of [177Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1321, doi. 10.1007/s00259-024-06979-1

By:

Zavvar, Taraneh Sadat;
Hörmann, Anton Amadeus;
Konijnenberg, Mark;
Kraihammer, Martin;
Mair, Christian;
Kronthaler, Ariane;
Joosten, Lieke;
Laverman, Peter;
Gruber, Leonhard;
di Santo, Gianpaolo;
Decristoforo, Clemens;
Virgolini, Irene;
von Guggenberg, Elisabeth

Publication type:

Article

αvβ6-integrin targeted [68Ga]Ga-Trivehexin PET/CT imaging of a rare bronchial mucoepidermoid carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1291, doi. 10.1007/s00259-024-06974-6

By:

Wu, Huiqin;
Li, Ling;
Xiao, Zhiwei;
Li, Chongjiao;
He, Yong

Publication type:

Article

[68Ga]Ga-PSMA-617 PET/MRI for imaging patients suspected of hepatocellular carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1278, doi. 10.1007/s00259-024-06973-7

By:

Qin, Chunxia;
Song, Xiangming;
Sun, Shiran;
Song, Yangmeihui;
Ruan, Weiwei;
Gai, Yongkang;
Yang, Ming;
Wan, Chidan;
Lan, Xiaoli

Publication type:

Article

Effect of molar dose on the in vivo tissue biodistribution profile of FAP-targeted radioligand therapeutics.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 4, p. 1399, doi. 10.1007/s00259-024-06969-3

By:

Galbiati, Andrea;
Bocci, Matilde;
Neri, Dario;
Cazzamalli, Samuele

Publication type:

Article

Correction to: Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programme.

Published in:

2025

By:

Vanhove, Christian;
Koole, Michel;
Fragoso Costa, Pedro;
Schottelius, Margret;
Mannheim, Julia;
Kuntner, Claudia;
Warnock, Geoff;
McDougald, Wendy;
Tavares, Adriana;
Bernsen, Monique

Publication type:

Correction Notice

Correction to: Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study.

Published in:

2025

By:

Carli, G.;
Kanel, P.;
Roytman, S.;
Pongmala, C.;
Albin, R. L.;
Raffel, D. M.;
Scott, P. J. H.;
Bohnen, N. I.

Publication type:

Correction Notice

Works matching IS 16197070 AND DT 2025 AND VI 52 AND IP 4

Cross-modality PET image synthesis for Parkinson's Disease diagnosis: a leap from [<sup>18</sup>F]FDG to [<sup>11</sup>C]CFT.

Association of objective subtle cognitive difficulties with amyloid-β and tau deposition compared to subjective cognitive decline.

[<sup>18</sup>F]FDG PET/CT for predicting neoadjuvant PD-L1 blockade monotherapy treatment response in patients with locally advanced esophageal squamous cell carcinoma: a preliminary study.

Dual-energy x-ray absorptiometry (DXA) in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM).

Molecular imaging: The bridge from human phenome to personalized precision medicine.

PSMA-targeted radioligand therapy in metastatic prostate cancer: Comprehensive analysis of recent evidence.

Cardiovascular disease and radiopharmaceutical therapies– an underestimated risk?

Assessment of fully quantitative and simplified methods for analysis of [<sup>68</sup>Ga]Ga-FAPI-46 uptake in patients with pancreatobiliary cancer using LAFOV PET/CT.

Exploration of (R)-[<sup>11</sup>C]YH168 as a PET tracer for imaging monoacylglycerol lipase in the brain: from mice to non-human primates.

Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [<sup>64</sup>Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study.

Human dose-escalation study of PET imaging CD8<sup>+</sup> T-cell infiltration in solid malignancies with [<sup>68</sup>Ga]Ga -NODAGA-SNA006.

Preclinical investigation of [<sup>149</sup>Tb]Tb-DOTATATE and [<sup>149</sup>Tb]Tb-DOTA-LM3 for tumor-targeted alpha therapy.

Subcortical tau deposition and plasma glial fibrillary acidic protein as predictors of cognitive decline in mild cognitive impairment and Alzheimer's disease.

Systematic review: Mechanisms of photoactive nanocarriers for imaging and therapy including controlled drug delivery.

Evaluation of long axial field-of-view (LAFOV) PET/CT for post-treatment dosimetry in Yttrium-90 radioembolization of liver tumors: a comparative study with conventional SPECT imaging.

Distinguishing benign from malignant lesions with high [<sup>68</sup> Ga]Ga-FAPI-04 uptake in oncology patients: Insights from dynamic total-body [<sup>68</sup> Ga]Ga-FAPI-04 PET/CT.

Preclinical comparison of (radio)lanthanides using mass spectrometry and nuclear imaging techniques: biodistribution of lanthanide-based tumor-targeting agents and lanthanides in ionic form.

A deep learning method for total-body dynamic PET imaging with dual-time-window protocols.

Evaluation of the safety, biodistribution, dosimetry of [<sup>18</sup>F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial.

Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia.

Phase I study of [<sup>68</sup>Ga]Ga-HX01 for targeting integrin αvβ3 and CD13 in healthy and malignancy subjects.

Preclinical safety and effectiveness of a long-acting somatostatin analogue [<sup>225</sup>Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors.

Self-supervised neural network for Patlak-based parametric imaging in dynamic [<sup>18</sup>F]FDG total-body PET.

The cerebellar glucose metabolism in moyamoya vasculopathy and its correlation with neurocognitive performance after cerebral revascularization surgery: a [<sup>18</sup>F]FDG PET study.

Presynaptic terminal integrity is associated with glucose metabolism in Parkinson's disease.

Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion.

Incorporating label uncertainty during the training of convolutional neural networks improves performance for the discrimination between certain and inconclusive cases in dopamine transporter SPECT.

Radioiodinated Nanobody immunoPET probe for in vivo detection of CD147 in pan-cancer.

Correction To: Coronary artery calcium measurement on attenuation correction computed tomography using artificial intelligence: correlation with coronary flow capacity and prognosis.

Comparison of clinical performance between late and standard total-body [<sup>68</sup> Ga]Ga-PSMA-11 in biochemical recurrent prostate cancer.

Radiopharmaceutical formulation and preliminary clinical dosimetry of [<sup>177</sup>Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy.

α<sub>v</sub>β<sub>6</sub>-integrin targeted [<sup>68</sup>Ga]Ga-Trivehexin PET/CT imaging of a rare bronchial mucoepidermoid carcinoma.

[<sup>68</sup>Ga]Ga-PSMA-617 PET/MRI for imaging patients suspected of hepatocellular carcinoma.

Effect of molar dose on the in vivo tissue biodistribution profile of FAP-targeted radioligand therapeutics.

Correction to: Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programme.

Correction to: Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study.